4.6 Article

Variance of SUVs for FDG-PET/CT is Greater in Clinical Practice Than Under Ideal Study Settings

Journal

CLINICAL NUCLEAR MEDICINE
Volume 38, Issue 3, Pages 175-182

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0b013e318279ffdf

Keywords

FDG; PET; SUV; clinical effectiveness; test-retest reproducibility; external validity

Funding

  1. NIH [U01-CA143062-01, R01-CA125627]
  2. Bristol-Myers Squibb
  3. Image Response Assessment Shared Service of the Moffitt Cancer Center

Ask authors/readers for more resources

Purpose: Measurement variance affects the clinical effectiveness of PET-based measurement as a semiquantitative imaging biomarker for cancer response in individual patients and for planning clinical trials. In this study, we measured test-retest reproducibility of SUV measurements under clinical practice conditions and recorded recognized deviations from protocol compliance. Methods: Instrument performance calibration, display, and analyses conformed to manufacture recommendations. Baseline clinical F-18-FDG PET/CT examinations were performed and then repeated at 1 to 7 days. Intended scan initiation uptake period was to repeat the examinations at the same time for each study after injection of 12 mCi FDG tracer. Avidity of uptake was measured in 62 tumors in 21 patients as SUV for maximum voxel (SUVmax) and for a mean of sampled tumor voxels (SUVmean). Results: The range of SUVmax and SUVmean was 1.07 to 21.47 and 0.91 to 14.69, respectively. Intraclass correlation coefficient between log of SUVmax and log of SUVmean was 0.93 (95% confidence interval [CI], 0.88-0.95) and 0.92 (95% CI, 0.87-0.95), respectively. Correlation analysis failed to show an effect on uptake period variation on SUV measurements between the 2 examinations, suggesting additional sources of noise. The threshold criteria for relative difference from baseline for the 95% CI were +/- 49% or +/- 44% for SUVmax or SUVmean, respectively. Conclusions: Variance of SUV for FDG-PET/CT in current clinical practice in a single institution was greater than expected when compared with benchmarks reported under stringent efficacy study settings. Under comparable clinical practice conditions, interpretation of changes in tumor avidity in individuals and assumptions in planning clinical trials may be affected.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk

Bethany L. Niell, Mahmoud Abdalah, Olya Stringfield, Natarajan Raghunand, Dana Ataya, Robert Gillies, Yoganand Balagurunathan

Summary: The use of quantitative BPE measures may outperform radiologist-assigned category in predicting breast cancer risk, especially at specific enhancement ratio thresholds like BPE%. Further research on risk prediction models incorporating quantitative measures is warranted.

AMERICAN JOURNAL OF ROENTGENOLOGY (2021)

Article Oncology

Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms race

Arig Ibrahim-Hashim, Kimberly Luddy, Dominique Abrahams, Pedro Enriquez-Navas, Sultan Damgaci, Jiqiang Yao, Tingan Chen, Marilyn M. Bui, Robert J. Gillies, Cliona O'Farrelly, Christina L. Richards, Joel S. Brown, Robert A. Gatenby

Summary: The progression of cancer is influenced by evolutionary dynamics in both the tumor population and its host. Host species can evolve defense strategies, both immunologic and non-immunologic, against tumors over generations. However, cancer cell plasticity allows for effective counter strategies against host defenses.

BRITISH JOURNAL OF CANCER (2021)

Article Immunology

Cognitive Performance and Neuro-Metabolites in HIV Using 3T Magnetic Resonance Spectroscopy: A Cross-Sectional Study from India

K. Gupta, Shivabalan, V Kumar, S. Vyas, R. M. Pandey, N. R. Jagannathan, S. Sinha

Summary: This study conducted in a tertiary care center in India found a high prevalence of cognitive impairment in ART naive patients with HIV, with a particular impact on simple motor skills and memory. However, there was no significant difference in brain metabolites concentration between patients with cognitive impairment and those without cognitive impairment. Further longitudinal studies are needed to understand the underlying pathophysiological mechanisms.

CURRENT HIV RESEARCH (2021)

Article Biophysics

Characterisation of prostate cancer using texture analysis for diagnostic and prognostic monitoring

Dharmesh Singh, Virendra Kumar, Chandan J. Das, Anup Singh, Amit Mehndiratta

Summary: By combining texture features and machine learning methods with DWI and ADC, the proposed framework can effectively differentiate between different grades of PCa, leading to improved diagnostic performance.

NMR IN BIOMEDICINE (2021)

Review Oncology

Cancer heterogeneity and metastasis: life at the edge

Robert J. Gillies

Summary: Evidence suggests that cells at the tumor stromal interface express higher levels of proteins related to glycolytic metabolism, leading to acid production which is associated with increased metastatic potential. The molecular machinery responsible for acid export is being studied, and neutralizing the acidity may prevent local invasion and metastasis.

CLINICAL & EXPERIMENTAL METASTASIS (2022)

Article Critical Care Medicine

Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules

Michael N. Kammer, Dhairya A. Lakhani, Aneri B. Balar, Sanja L. Antic, Amanda K. Kussrow, Rebekah L. Webster, Shayan Mahapatra, Udaykamal Barad, Chirayu Shah, Thomas Atwater, Brenda Diergaarde, Jun Qian, Alexander Kaizer, Melissa New, Erin Hirsch, William J. Feser, Jolene Strong, Matthew Rioth, York E. Miller, Yoganand Balagurunathan, Dianna J. Rowe, Sherif Helmey, Sheau-Chiann Chen, Joseph Bauza, Stephen A. Deppen, Kim Sandler, Fabien Maldonado, Avrum Spira, Ehab Billatos, Matthew B. Schabath, Robert J. Gillies, David O. Wilson, Ronald C. Walker, Bennett Landman, Heidi Chen, Eric L. Grogan, Anna E. Baron, Darryl J. Bornhop, Pierre P. Massion

Summary: Combining clinical, blood, and image biomarkers improves the noninvasive diagnosis of patients with IPNs, potentially reducing unnecessary invasive procedures and shortening the time to diagnosis.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Oncology

Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer

Asmaa El-Kenawi, William Dominguez-Viqueira, Min Liu, Shivanshu Awasthi, Julieta Abraham-Miranda, Aysenur Keske, KayLee K. Steiner, Leenil Noel, Amparo N. Serna, Jasreman Dhillon, Robert J. Gillies, Xiaoqing Yu, John M. Koomen, Kosj Yamoah, Robert A. Gatenby, Brian Ruffell

Summary: The study shows that tumor-associated macrophages play a crucial role in CRPC by regulating cholesterol metabolism to impact androgen biosynthesis.

CANCER RESEARCH (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

IVIM-DKI for differentiation between prostate cancer and benign prostatic hyperplasia: comparison of 1.5 T vs. 3 T MRI

Archana Vadiraj Malagi, Arjunlokesh Netaji, Virendra Kumar, Esha Baidya Kayal, Kedar Khare, Chandan Jyoti Das, Fernando Calamante, Amit Mehndiratta

Summary: Implementing an advanced spatial penalty-based reconstruction at 1.5 T can provide a suitable alternative to the traditional IVIM-DKI model at 3 T for clinical characterization of prostate cancer and benign prostatic hyperplasia. The novel model with TV spatial penalty function showed lower estimation errors and improved detection of prostate lesions compared to the traditional model. Parameters estimated using the novel model at 1.5 T demonstrated high diagnostic performance in cancer lesion detection.

MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Differentiation between sepsis survivors and sepsis non-survivors through blood serum metabolomics: A proton nuclear magnetic resonance spectroscopy (NMR) study

Mylathal Sivasamy Naveen Kumar, Gaurav Gupta, Virendra Kumar, Naranamangalam R. Jagannathan, Sanjeev Sinha, Sujeeth Mewar, Pradeep Kumar

Summary: This study used NMR spectroscopy to analyze the metabolic profiles of serum samples from patients with sepsis, and discovered differences between non-survivors and survivors. The findings suggest that the metabolic alterations at day zero may predict the survival of patients with sepsis.

MAGNETIC RESONANCE IMAGING (2022)

Article Multidisciplinary Sciences

Untargeted metabolomics-based response analysis of temperature and insecticide exposure in Aedes aegypti

Poonam Singh, Pradeep Kumar, Veena Pande, Virendra Kumar, Ramesh C. Dhiman

Summary: In this study, the vector response to temperature and insecticide exposure was investigated using untargeted NMR metabolomics. The results revealed changes in various metabolites and pathways. Furthermore, the study showed that the effects of temperature and insecticide exposure were reversed when they were combined, posing a threat to the control of vector-borne diseases.

SCIENTIFIC REPORTS (2022)

Article Oncology

Images Are Data: Challenges and Opportunities in the Clinical Translation of Radiomics

Wei Mu, Matthew B. Schabath, Robert J. Gillies

Summary: Radiomics provides an opportunity to uncover image-based biomarkers by converting and analyzing medical images into high-dimensional mineable data. However, the lack of a generally accepted analytic and reporting standard makes interstudy comparisons challenging. Comparing and combining results from multiple studies is essential for clinical application.

CANCER RESEARCH (2022)

Article Oncology

Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes

Audrey R. Freischel, Jamie K. Teer, Kimberly Luddy, Jessica Cunningham, Yael Artzy-Randrup, Tamir Epstein, Kenneth Y. Tsai, Anders Berglund, John L. Cleveland, Robert J. Gillies, Joel S. Brown, Robert A. Gatenby

Summary: Evolution plays a crucial role in the initiation and progression of cancer. In addition to driver mutations, natural selection conserves genes that are necessary for optimal cancer cell fitness. By studying subtypes of lung adenocarcinoma, we identified highly mutated and highly conserved genes, which have common utility in adapting to similar tissue environments and are critical for optimal fitness. Targeting tumor-specific conserved genes may represent an effective treatment strategy.

CANCERS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

AI-Radiomics Can Improve Inclusion Criteria and Clinical Trial Performance

Michal R. Tomaszewski, Shuxuan Fan, Alberto Garcia, Jin Qi, Youngchul Kim, Robert A. Gatenby, Matthew B. Schabath, William D. Tap, Denise K. Reinke, Rikesh J. Makanji, Damon R. Reed, Robert J. Gillies

Summary: This study presents a novel clinical-radiomic approach for patient enrichment in clinical trials. The results show that by using an appropriate model for selective patient inclusion, the SARC021 trial could have achieved its primary survival objective for patients with metastatic soft-tissue sarcoma.

TOMOGRAPHY (2022)

Proceedings Paper Engineering, Biomedical

Deep Radiomics: Deep Learning on Radiomics Texture Images

Rahul Paul, Sherzod Kariev, Dmitry Cherezov, Matthew B. Schabath, Robert J. Gillies, Lawrence O. Hall, Dmitry B. Goldgof

Summary: Radiomics is utilized for predicting the malignancy of lung nodules, and training CNN with texture images can improve classification accuracy, termed as Deep Radiomics.

MEDICAL IMAGING 2021: COMPUTER-AIDED DIAGNOSIS (2021)

Article Computer Science, Information Systems

Triphasic DeepBRCA-A Deep Learning-Based Framework for Identification of Biomarkers for Breast Cancer Stratification

Sheetal Rajpal, Manoj Agarwal, Virendra Kumar, Anamika Gupta, Naveen Kumar

Summary: Through the deep learning framework Triphasic DeepBRCA, classification of breast cancer subtypes based on gene expression data was achieved, identifying 54 most variant genes, with over 30 genes significantly linked to prognostic outcomes.

IEEE ACCESS (2021)

No Data Available